Marlies Reinders new Dean of Faculty of Medicine and member of LUMC Board of Directors
As of 1 October, Marlies Reinders (1973) will be the new Dean of the Faculty of Medicine and will sit on the LUMC’s Board of Directors. This will return the board to full strength.
The LUMC is familiar territory for Marlies Reinders. She worked there as an internist-nephrologist for 15 years and did a lot of work on kidney transplant research and training. She has been Chair of the Transplant Institute, Head of Nephrology and Transplantation and Professor of Internal Medicine and Kidney Transplantation at Erasmus MC since 2020. Reinders will return to the ‘innovation motor’, as she calls the LUMC, on 1 October.
‘We are delighted that Marlies Reinders is joining our Board of Directors’, says Jacques van den Broek, Chair of the Supervisory Council. ‘Her extensive experience and vision on care, innovation and education are a great match for the LUMC’s position and ambitions. Marlies’ appointment will allow us to continue strengthening our organisation and our position both within and outside the region.’ Douwe Biesma, Chair of the Board of Directors, adds, ‘Marlies is the right person for the job and we look forward to working with her.’
Reinders will focus primarily on working in knowledge networks to make the latest treatment accessible to the largest possible number of patients. ‘We also need to look carefully at societal challenges and tailor our research and teaching accordingly. The number of chronically ill patients is increasing. How can we prevent this? How can we predict what health risks people will face? And how can technical innovation help? I see an important role for the LUMC in this.’
The members of the Board of Directors will be as follows from 1 October 2024:
Douwe Biesma (Chair), Martin Jan Schalij, Frida van den Maagdenberg and Marlies Reinders.